https://www.selleckchem.com/pr....oducts/VX-680(MK-045
6 ± 18.6%), and this increased significantly at 6-month follow-up (P0.0001). Chest CT scans showed a high prevalence (68.9% of the cohort) of persistent abnormalities, mainly ground glass opacities. Duration of hospitalization, intensive care unit admission and mechanical ventilation were not associated with the persistence of symptoms 3 months after discharge. The prevalence of persistent symptoms following hospitalization with COVID-19 is high and stable for up to 6 months after discharge. However, biological, functional a
Like
Comment
Share
